Pro Share Advisors LLC Krystal Biotech, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 6,881 shares of KRYS stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,881

Previous 5,154 33.51%

Holding current value

$1.35 Million

Previous $946,000 32.24%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$174.7 - $213.66 $301,706 - $368,990	1,727 Added 33.51%	6,881 $1.25 Million
Q2 2024 Aug 13, 2024	SELL	$153.12 - $183.64 $108,868 - $130,568	-711 Reduced 12.12%	5,154 $946,000
Q1 2024 May 08, 2024	BUY	$108.01 - $179.35 $52,492 - $87,164	486 Added 9.04%	5,865 $1.04 Million
Q4 2023 Feb 14, 2024	BUY	$96.0 - $128.29 $71,040 - $94,934	740 Added 15.95%	5,379 $667,000
Q3 2023 Nov 13, 2023	BUY	$108.51 - $130.22 $17,144 - $20,574	158 Added 3.53%	4,639 $538,000
Q2 2023 Aug 10, 2023	BUY	$78.48 - $130.32 $14,518 - $24,109	185 Added 4.31%	4,481 $526,000
Q1 2023 May 11, 2023	SELL	$72.39 - $84.27 $41,769 - $48,623	-577 Reduced 11.84%	4,296 $343,000
Q4 2022 Feb 02, 2023	BUY	$63.14 - $79.9 $22,856 - $28,923	362 Added 8.02%	4,873 $386,000
Q3 2022 Nov 04, 2022	BUY	$64.85 - $82.4 $10,440 - $13,266	161 Added 3.7%	4,511 $315,000
Q2 2022 Aug 01, 2022	SELL	$48.93 - $73.47 $99,230 - $148,997	-2,028 Reduced 31.8%	4,350 $285,000
Q1 2022 May 10, 2022	SELL	$51.99 - $72.11 $34,729 - $48,169	-668 Reduced 9.48%	6,378 $424,000
Q4 2021 Feb 08, 2022	BUY	$39.81 - $88.24 $199 - $441	5 Added 0.07%	7,046 $493,000
Q3 2021 Nov 12, 2021	SELL	$52.01 - $71.77 $83,216 - $114,832	-1,600 Reduced 18.52%	7,041 $368,000
Q2 2021 Aug 13, 2021	BUY	$62.14 - $81.82 $98,243 - $129,357	1,581 Added 22.39%	8,641 $588,000
Q1 2021 May 14, 2021	BUY	$59.42 - $85.46 $60,727 - $87,340	1,022 Added 16.93%	7,060 $544,000
Q4 2020 Feb 09, 2021	BUY	$40.64 - $61.38 $245,384 - $370,612	6,038 New	6,038 $362,000

Others Institutions Holding KRYS

# of Institutions

311

Shares Held

24.4M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $5.04B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Krystal Biotech, Inc. Transaction History